Works matching IS 20420986 AND DT 2022 AND VI 13
Results: 35
Risk communication on vaccines during the COVID19 pandemic: is there room for small size or private initiatives? An Israeli experience.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221112189
- By:
- Publication type:
- Article
Patients' views on Self-administration of Medication during hospitalisation: a mixed-methods study.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221107804
- By:
- Publication type:
- Article
Safety surveillance and challenges in accelerated COVID-19 vaccine development.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221116452
- By:
- Publication type:
- Article
Drug safety of frequently used drugs and substances for self-medication in COVID-19.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221094141
- By:
- Publication type:
- Article
Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221146411
- By:
- Publication type:
- Article
Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221143266
- By:
- Publication type:
- Article
A survey on self-medication for the prevention or treatment of COVID-19 and distrust in healthcare of veterans in a primary care setting in the United States.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221143265
- By:
- Publication type:
- Article
Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221135931
- By:
- Publication type:
- Article
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cancer risk: an updated meta-analysis of observational studies.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221129335
- By:
- Publication type:
- Article
Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221127503
- By:
- Publication type:
- Article
Definition of self-medication: a scoping review.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221127501
- By:
- Publication type:
- Article
Pharmacovigilance: reporting requirements throughout a product's lifecycle.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221125006
- By:
- Publication type:
- Article
Increasing patient involvement through self-administration of medication.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Development of a deprescribing manual for frail older people for use in the COFRAIL study and in primary care.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221122684
- By:
- Publication type:
- Article
Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221118972
- By:
- Publication type:
- Article
Motivating deprescribing conversations for patients with Alzheimer's disease and related dementias: a descriptive study.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221118143
- By:
- Publication type:
- Article
Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221116468
- By:
- Publication type:
- Article
Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221116465
- By:
- Publication type:
- Article
Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral molnupiravir?
- Published in:
- 2022
- By:
- Publication type:
- Letter
Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221101963
- By:
- Publication type:
- Article
A case report of drug-induced liver injury due to the infliximab biosimilar CT-P13 on switching from original infliximab in a patient with Crohn's disease.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221100118
- By:
- Publication type:
- Article
The patterns and implications of potentially suboptimal medicine regimens among older adults: a narrative review.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221100117
- By:
- Publication type:
- Article
Polypharmacy and potential drug–drug interactions among Greenland's care home residents.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221103918
- By:
- Publication type:
- Article
Prescription for COVID-19 by non-medical professionals during the pandemic in Colombia: a cross-sectional study.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221101964
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2022
- Publication type:
- Correction Notice
Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986211072383
- By:
- Publication type:
- Article
The 5 th European pharmacovigilance congress: speaker abstracts.
- Published in:
- 2022
- Publication type:
- Abstract
Trends in potentially inappropriate opioid prescribing and associated risk factors among Korean noncancer patients prescribed non-injectable opioid analgesics.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221091001
- By:
- Publication type:
- Article
The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Neurodevelopmental outcomes in children exposed prenatally to levetiracetam.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221088419
- By:
- Publication type:
- Article
Ten-year trends in adverse drug reaction–related hospitalizations among people with dementia.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221080796
- By:
- Publication type:
- Article
Prevalence and global trends of polypharmacy among people living with HIV: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221080795
- By:
- Publication type:
- Article
Alkalising agents in urinary tract infections: theoretical contraindications, interactions and synergy.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221080794
- By:
- Publication type:
- Article
Self-medication and the 'infodemic' during mandatory preventive isolation due to the COVID-19 pandemic.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986221072376
- By:
- Publication type:
- Article
Use of an electronic medication management support system in patients with polypharmacy in general practice: study protocol of a quantitative process evaluation of the AdAM trial.
- Published in:
- Therapeutic Advances in Drug Safety, 2022, v. 13, p. 1, doi. 10.1177/20420986211073215
- By:
- Publication type:
- Article